Schiariti, M., Saladini, A., Papalia, F., Grillo, P., Nesta, C., Cuturello, D., . . . Puddu, P. E. (2010). GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin. Bentham Open.

Schiariti, Michele, Angela Saladini, Francesco Papalia, Placido Grillo, Cristina Nesta, Domenico Cuturello, Bindo Missiroli, and Paolo Emilio Puddu. GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides No Additive Long-Term Protection After Percutaneous Coronary Intervention As Compared to Clopidogrel Plus Aspirin. Bentham Open, 2010.

Schiariti, Michele, et al. GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides No Additive Long-Term Protection After Percutaneous Coronary Intervention As Compared to Clopidogrel Plus Aspirin. Bentham Open, 2010.